Machine signal
Active cluster sell — 3 distinct insiders, $128.3K, window ends Sep 18, 2026.
Figures computed from official regulatory filings — .
Analysttarget 29 USD (+573%) · consensus 4/5 · 2 buy · 2 hold · 0 sell
Ownershipinsiders 3.47% · institutions 27.92% · short 1.3% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Bolt Biotherapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company's pipeline products include BDC-4182, a next-generation Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program for the treatment of non-small cell lung cancer, melanoma, and other solid tumors; CEA ISAC, a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5 for the treatment of solid tumors, including colorectal, non-small cell lung, pancreatic, and breast; and PD-L1 ISAC, a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker to target both tumor and immune cells for the treatment of tumor regression and immunological memory. The company has collaboration agreements with Toray Industries, Genmab A/S, and Innovent Biologics, Inc.; and a license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.
Market information source · Oct 19, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 19, 2026
Open-market timeline · full history
44 buys40 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Yonehiro Grant | Sell | $22.2K | SEC |
| Quinn William P.track record | Sell | $21.7K | SEC |
| Yonehiro Grant | Sell | $16.3K | SEC |
| Quinn William P.track record | Sell | $7.1K | SEC |
| Nemec Sarahtrack record | Buy | $2K | conv 54 | SEC |
| Quinn William P.track record | Buy | $2.5K | conv 30 | SEC |
| Nemec Sarahtrack record | Sell | $13.2K | SEC |
| Nemec Sarahtrack record | Sell | $9.7K | SEC |
| Quinn William P.track record | Sell | $29.6K | SEC |
| Nemec Sarahtrack record | Sell | $3.2K | SEC |
| Yonehiro Grant | Sell | $5.3K | SEC |
| O'CALLAGHAN BRIAN | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Berner Laura | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| LAPORTE KATHLEENtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| ONETTO NICOLE | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Dupont Jakob | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Quinn William P.track record | Buy | $576.3 | conv 21 | SEC |
| Quinn William P.track record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Nemec Sarahtrack record | Buy | $576.3 | conv 29 | SEC |
| Yonehiro Grant | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Nemec Sarahtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Yonehiro Grant | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Nemec Sarahtrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| LAPORTE KATHLEENtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Berner Laura | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |